Wegovy (semaglutide) targets GLP-1 receptors, while Zepbound (tirzepatide) targets both GLP-1 and GIP receptors
Hormonal Imbalances Hormones influence metabolism, fat storage, and energy levels
Insurance typically does not cover peptide therapy
Incorporating foods rich in fiber, such as fruits, vegetables, whole grains, and legumes, can promote healthy bowel movements
For dairy brands, fiber and biotics fortification will play a greater role than ever, as will consumer education
A number of studies have shown that GLP-/GIPR dual agonists can achieve better blood glucose control, insulin sensitivity, lipid metabolism and weight loss compared with GLP-1 alone [136,137]